Santé & Pharma

PIU’ MEDICAL COMUNICAZIONE INTERMEDIA DURANTE IL PERIODO DI STABILIZZAZIONE

PIU’ MEDICAL INTERIM COMMUNICATION DURING THE STABILIZATION PERIOD

PIU’ MEDICAL PIÙ MEDICAL AMMESSA ALLE NEGOZIAZIONI SU EURONEXT GROWTH MILAN

PIU’ MEDICAL SPA

39 M

PLx Pharma Inc.

PMV Pharmaceuticals, Inc.

60 M

PNV

698 M

POD

10 Md

POINT Biopharma Global Inc.

POLARITYTE, INC.

POXEL

20 M

PPD, Inc.

PPD, Inc.

PRA Health Sciences, Inc.

PREDILIFE

10 M

PRIM S.A

PRIM, S.A.

PRIM, S.A.

220 M

PRO DEX INC

208 M

PRO MEDEX

287 M

PROCEPT BioRobotics Corp

1,5 Md

PROCYON CORP

1,9 M

PROGENITY, INC.

PSYCHEMEDICS CORP

15 M

PTC Therapeutics, INC.

6,1 Md

PZ Cormay S.A.

44 M

Pacific Biosciences of California, INC.

419 M

Pacific Health Care Organization INC

14 M

Pacira BioSciences, Inc.

914 M

Palatin Technologies INC

25 M

Palisade Bio, INC.

292 M

Panacea Biotec Limited

25 Md

Panacea Life Sciences Holdings, INC.

594 k

Panbela Therapeutics, Inc.

54 k

Paragon 28, Inc.

Paratek Pharmaceuticals, Inc.

Pardes Biosciences, INC.

Park Dental Partners, Inc.

82 M

Pasithea Therapeutics Corp.

Passage BIO, Inc.

17 M

Patterson Companies, INC.

Paxman AB (publ)

1,2 Md

Paxman AB (publ)

1,2 Md

Peak Processing Limited

17 M

Pear Therapeutics, Inc.

Pediatrix Medical Group, Inc.

2 Md

Peijia Medical Ltd. - B

2,7 Md

Pelthos Therapeutics Inc.

95 M

Pennant Group, Inc.

1,1 Md

Pentixapharm Holding AG

53 M